Combating the Increase in Counterfeit Medicines
Shadow Rapporteur - Information to Patients, European Parliament
Dr. Jorgo Chatzimarkakis MEP is a member of the European Parliament Committee on Industry, Research and Energy (ITRE) and of the Committee on Budgetary Control
(CONT). He is also a Substitute on the Committee for Environment, Public Health and Food Safety (ENVI). He was already elected Member of the European Parliament for the German Liberal Party (FDP) in 2004.
Dr. Chatzimarkakis has been actively involved in developing directives on a wide range of subjects, most notably innovation issues (CIP) as well as education and research
policies (EIT). In the 6th term of the European Parliament, he was Rapporteur for the
Competitiveness and Innovation Framework Programme.
Since 2006 Dr. Chatzimarkakis is member of the Pharmaceutical Forum, a high level group designed to provide a political mandate for relevant public health issues. He launched the European Life Science Circle (ELSC), a platform to discuss relevant issues in the context of life sciences and pharmaceuticals.
In 2009 Mr Chatzimarkakis was re-elected into the European Parliament and became Chairman of the EP-Delegation for the former Yugoslav Republic of Macedonia (FYROM). Additionally, he became Vice-President of the World Hellenic Inter- Parliamentary Association (WHIA).
Jorgo Chatzimarkakis studied agriculture and political sciences in Bonn and Oxford and holds a PhD in political science.
EU Qualified Person for Pharmacovigilance, AstraZeneca
Dr Arnold qualified as a medical practitioner in 1980. After becoming a Fellow of the Royal College of Anaesthetists, he joined the pharmaceutical industry in 1986, gaining experience in all phases of clinical development.
From 1992-2006, Dr Arnold was the Head of Drug Safety for ICI, Zeneca and AstraZeneca, and was appointed as the EU Qualified Person for Pharmacovigilance in June 2006.
Dr Arnold chairs the EFPIA Pharmacovigilance ad hoc group, and is a member of the EFPIA MedDRA Topic Group and EFPIA Clinical Trials Directive Working Party. He has represented EFPIA on the MedDRA Management Board, the ICH E2E (Pharmacovigilance Planning) and ICH E2F (Development Safety Update Report) Expert Working Groups.
Combating the Increase in Counterfeit Medicines
Legal Advisor, European Association of Pharmaceutical Full-Line Wholesalers
GIRP is the European association which is headquartered in Brussels (Belgium) and brings together the over 600 pharmaceutical full-line wholesaling companies and their national associations from 31 European countries.
Martin advises the association on a matrix of pharmaceutical and legal issues impacting upon the interests of the pharmaceutical full-line wholesale sector in Europe. He also represents the association externally and in this respect works with the European institutions such as the European Commission, the European Parliament and the Council as well as with other European and International organisations such as the Council of Europe and the WHO. Another important part of his work consists in liaising with European stakeholder associations and national health authorities.
Information to Patients: Moving the Debate Forward
Head of the Health Department, BEUC (The European Consumers Organisation
Ilaria Passarani joined BEUC in 2006. As head of the BEUC health department, her main function is to provide BEUC and its members, intelligence, information and advice on EU health policies. Ilaria is a member of the European Medicines Agency committee with patients and consumers organization (PCWP) and represents BEUC in the EU health policy Forum and in the e-health users’ stakeholders group. She is also scientific researcher at the Faculty of health, medicine and life science of the Maastricht University. She previously worked in the International health and social affairs office of the Veneto Regional Government and in the health department of the Italian Permanent Representation to the European Union. Ilaria studied Economics at Bocconi University in Milan (Italy) and health economics at the Harvard School for Public Health (USA).
Chief Technology Officer, Reg. Pharmacist, LIF - The Swedish Association of the Pharmaceutical Industry
Reg. pharmacist. Current position Chief Technology Officer at the Swedish Association of the Pharmaceutical Industry, LIF.
Have held various director positions at the Medical Products Agency. Advisor to the World Health Organization on essential dugs, drug information and pharmacovigilance
Vice-President, Standing Commitee of European Doctors
Roland Lemye, born in Gosselies on 25 November 1946, graduated from the Université Libre de Bruxelles in 1971. He has been established as general practitioner since 1971. He is also a Professor at Université Libre de Bruxelles. For the term 2007-2010, he is President of the Belgian Association of Medical Unions in charge of international affairs. From 1998-1999 and 2000-2001, he was Chairman of the subcommittee Ethics and Professional Codes of the Standing Committee of European Doctors and was elected CPME Treasurer for 2006-2007 and re-elected for 2008-2009. He furthermore holds the positions of adviser to the Committee of Ethics of the World Medical Association and is chairman of MED MEDICA.